Logo image of BHM

BLUEROCK HOMES TRUST INC (BHM) Stock Fundamental Analysis

NYSEARCA:BHM - American Stock Exchange - US09631H1005 - Common Stock

12.54  +0.14 (+1.13%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to BHM. BHM was compared to 20 industry peers in the Residential REITs industry. The financial health of BHM is average, but there are quite some concerns on its profitability. BHM is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

In the past year BHM has reported negative net income.
BHM had a positive operating cash flow in the past year.
BHM Yearly Net Income VS EBIT VS OCF VS FCFBHM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 0 100M -100M -200M

1.2 Ratios

BHM has a Return On Assets of -0.41%. This is in the lower half of the industry: BHM underperforms 60.00% of its industry peers.
With a Return On Equity value of -1.44%, BHM is not doing good in the industry: 70.00% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -0.41%
ROE -1.44%
ROIC N/A
ROA(3y)5.89%
ROA(5y)N/A
ROE(3y)6.41%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BHM Yearly ROA, ROE, ROICBHM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 10 20

1.3 Margins

The Gross Margin of BHM (42.65%) is worse than 95.00% of its industry peers.
In the last couple of years the Gross Margin of BHM has declined.
The Profit Margin and Operating Margin are not available for BHM so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 42.65%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-21.12%
GM growth 5YN/A
BHM Yearly Profit, Operating, Gross MarginsBHM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 0 200 -200 400 600

4

2. Health

2.1 Basic Checks

BHM does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, BHM has more shares outstanding
BHM has a worse debt/assets ratio than last year.
BHM Yearly Shares OutstandingBHM Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 1M 2M 3M
BHM Yearly Total Debt VS Total AssetsBHM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 200M 400M 600M

2.2 Solvency

BHM has an Altman-Z score of 0.30. This is a bad value and indicates that BHM is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 0.30, BHM is not doing good in the industry: 80.00% of the companies in the same industry are doing better.
A Debt/Equity ratio of 0.90 indicates that BHM is somewhat dependend on debt financing.
BHM has a Debt to Equity ratio (0.90) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.9
Debt/FCF N/A
Altman-Z 0.3
ROIC/WACCN/A
WACC5.72%
BHM Yearly LT Debt VS Equity VS FCFBHM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 0 200M -200M 400M

2.3 Liquidity

A Current Ratio of 4.86 indicates that BHM has no problem at all paying its short term obligations.
The Current ratio of BHM (4.86) is better than 100.00% of its industry peers.
A Quick Ratio of 4.86 indicates that BHM has no problem at all paying its short term obligations.
BHM's Quick ratio of 4.86 is amongst the best of the industry. BHM outperforms 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 4.86
Quick Ratio 4.86
BHM Yearly Current Assets VS Current LiabilitesBHM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 20M 40M 60M 80M 100M

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 17.67% over the past year.
BHM shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 16.37%.
Measured over the past years, BHM shows a very strong growth in Revenue. The Revenue has been growing by 77.33% on average per year.
EPS 1Y (TTM)17.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%184.97%
Revenue 1Y (TTM)16.37%
Revenue growth 3Y77.33%
Revenue growth 5YN/A
Sales Q2Q%24.81%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BHM Yearly Revenue VS EstimatesBHM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 10M 20M 30M 40M
BHM Yearly EPS VS EstimatesBHM Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023

0

4. Valuation

4.1 Price/Earnings Ratio

BHM reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BHM Price Earnings VS Forward Price EarningsBHM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, BHM is valued more expensive than 95.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 42.98
BHM Per share dataBHM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

BHM does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

BLUEROCK HOMES TRUST INC

NYSEARCA:BHM (1/21/2025, 8:04:02 PM)

12.54

+0.14 (+1.13%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryResidential REITs
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners34.4%
Inst Owner ChangeN/A
Ins Owners10.52%
Ins Owner Change0%
Market Cap49.66M
AnalystsN/A
Price TargetN/A
Short Float %0.18%
Short Ratio1.09
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.02
Dividend Growth(5Y)N/A
DP-172.84%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.06
P/FCF N/A
P/OCF 4.46
P/B 0.22
P/tB 0.22
EV/EBITDA 42.98
EPS(TTM)-0.86
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-13.91
FCFYN/A
OCF(TTM)2.81
OCFY22.44%
SpS11.85
BVpS57.81
TBVpS57.69
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.41%
ROE -1.44%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 42.65%
FCFM N/A
ROA(3y)5.89%
ROA(5y)N/A
ROE(3y)6.41%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-21.12%
GM growth 5YN/A
F-Score3
Asset Turnover0.06
Health
Industry RankSector Rank
Debt/Equity 0.9
Debt/FCF N/A
Debt/EBITDA 72.93
Cap/Depr 334.93%
Cap/Sales 141.2%
Interest Coverage N/A
Cash Conversion 392.39%
Profit Quality N/A
Current Ratio 4.86
Quick Ratio 4.86
Altman-Z 0.3
F-Score3
WACC5.72%
ROIC/WACCN/A
Cap/Depr(3y)1202.97%
Cap/Depr(5y)N/A
Cap/Sales(3y)764.82%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)17.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%184.97%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)16.37%
Revenue growth 3Y77.33%
Revenue growth 5YN/A
Sales Q2Q%24.81%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-22.54%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y79.2%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-28.93%
OCF growth 3Y-1.64%
OCF growth 5YN/A